Graystone Eye is a clinical research site located in Hickory, North Carolina, United States 28602.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Graystone Eye has participated in 14 clinical trials with 5 currently active.
Therapeutic areas: Diabetic Macular Edema, Wet Macular Degeneration, Non-proliferative Diabetic Retinopathy.
Sponsors: Genentech, Inc., Hoffmann-La Roche, Kodiak Sciences Inc.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Graystone Eye has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Graystone Eye has 14 clinical trials on record, with 5 currently active. Their work covers Diabetic Macular Edema, Wet Macular Degeneration, Non-proliferative Diabetic Retinopathy.
Yes — Graystone Eye holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.